ArticleFrontiers in pharmacology2025

Real-world data analysis of the risk of Fournier's gangrene in patients using sodium-glucose cotransporter 2 inhibitors (SGLT2i).

Moritz Hertel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.